Antiviral treatment starts Phase II trial

Israeli-founded SaNOtize, has been granted approval by Health Canada to conduct a Phase II trial for its antiviral early treatment against COVID-19. The Nitric Oxide Releasing Solution (NORS) was effective in the lab against influenza A, hCoV-OC43 and H1N1 (swine flu).

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *